Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
A loss of -2.080% shows a downward development for Twist Bioscience Corp.
We see a rather positive sentiment for Twist Bioscience Corp with 9 Buy predictions and 2 Sell predictions.
With a target price of 41 € there is a hugely positive potential of 55.54% for Twist Bioscience Corp compared to the current price of 26.36 €.
So far the community has only identified positive things for Twist Bioscience Corp stock. The most positive votes were given for criterium "Revenue growth".
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -2.080% | -5.009% | -4.111% | -41.759% | -42.357% | 8.611% | -77.470% |
| Pacira Pharmaceuticals | 1.900% | 4.902% | 4.902% | 14.439% | 15.676% | -49.528% | -53.275% |
| Rockwell Medical Inc. | -0.990% | -5.729% | -2.742% | -59.451% | -60.417% | -14.194% | -92.157% |
| Vericel Corp. | 0.000% | 1.935% | -10.734% | -42.018% | -42.018% | 42.471% | 39.514% |
Comments
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Evercore ISI from $46.00 to $42.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
The comment is under review
